Aventis Pharma
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 16, 2012 at 16:33 | Source: PTI
May 04, 2012 at 12:43 | Source: Moneycontrol.com
Apr 10, 2012 at 11:27 | Source: Moneycontrol.com
Feb 24, 2012 at 08:19 | Source: CNBC-TV18
News across the web »
May 16, 2012 at 20:44 | Source: The Hindu BusinessLine
May 07, 2012 at 12:42 | Source: Economic Times
May 04, 2012 at 14:06 | Source: FirstPost
May 03, 2012 at 09:26 | Source: Economic Times
May 03, 2012 at 08:51 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
Sanofi Group's listed entity in India, today announced that the Registrar of Companies had approved the company's change of name from Aventis Pharma Ltd to 'Sanofi India Ltd', with effect from May 11. The shareholders of the company had earlier ...
May 16, 2012 at 11:14 | Source: MoneyControl.com
The TAC and Section 27 have joined the fray in a face-off between Aventis Pharma and Cipla Life Sciences in a patent war over cancer drug Docetaxel. The case is of interest to healthcare lobbyists because it could advance patients’ right to access ...
May 16, 2012 at 05:37 | Source: Mail & Guardian Online
One coauthor reports board memberships from Bayer and Boehringer Ingelheim and receiving lecture fees from Bayer, Boehringer Ingelheim, Pfizer, and sanofi-aventis. One coauthor board memberships from Bristol-Myers Squibb, Pfizer, and Bayer Schering Pharma ...
May 25, 2012 at 21:33 | Source: Medscape News
In Aventis Pharma S.A. vs. Hospira Inc., Fed. Cir. App. No 2011-1018, April 9, 2012, the Federal Circuit affirmed a judgment of inequitable conduct rendered after a bench trial. Significantly, that judgment was rendered prior to the Federal Circuit's ...
May 14, 2012 at 18:33 | Source: Mondaq
The rupee was trading at Rs 53.19 to the dollar at the time of writing. Barring Aventis Pharma, all MNC pharma stocks closed in the red today. Aventis Pharma declared results for the first quarter ended March 2012. The clocked 16.4% YoY growth in sales ...
May 8, 2012 at 21:24 | Source: MSN India
Clopidogrel pills are the generic edition of Sanofi Aventis' Plavix tabs. Dr Reddy's has got nod for pills in potencies of 75 mg and 300 mg, whereas Aurobindo Pharma and Sun Pharma got USFDA's sanction for the pills in 75 mg strength. As per IMS Health ...
May 19, 2012 at 06:45 | Source: Top News India
(RTTNews) - Aurobindo Pharma Ltd. announced that it had received final approval ... Clopidogrel tablets USP 75 mg is the generic equivalent of Aventis US LLC (Sanofi)'s Plavix tablets USP 75 mg. The product falls under the cardio-vascular (CVS) therapeutic ...
May 18, 2012 at 07:44 | Source: RTT News
Marketed by Sanofi-Aventis in 75 mg and 300 mg tablets ... Mylan Pharmaceuticals Inc and Teva to share marketing exclusivity with Dr Reddy’s Lab Sun Pharma, Torrent Pharma and Aurobindo Pharma to sell the drug in 75 mg; Dr Reddy's to sell in 75 mg ...
May 18, 2012 at 19:25 | Source: Business Standard
Plavix, whose generic name is clopidogrel, was made and marketed through a partnership of Sanofi-Aventis and Bristol-Myers Squibb ... Teva, Apotex Corp., Aurobindo Pharma, Mylan, Roxane Laboratories, Sun Pharma and Torrent Pharmaceuticals ...
May 19, 2012 at 09:51 | Source: Philadelphia Daily News
Mumbai, May 18 (PTI) Pharma major Dr Reddy's Laboratories and Nasdaq listed ... Clopidogrel is the generic version of Sanofi-Aventis' Plavix, and is indicated for acute coronary syndrome and for patients with a recent history of myocardial ...
May 17, 2012 at 23:58 | Source: in.com